Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain.
Visual search as a tool for a quick and reliable assessment of cognitive functions in patients with multiple sclerosis.
EphrinB1 and EphrinB2 regulate T cell chemotaxis and migration in experimental autoimmune encephalomyelitis and multiple sclerosis.
Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits.
Conventional housing conditions attenuate the development of experimental autoimmune encephalomyelitis.
An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer.
A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.
A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology.
Unethical for neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support.
Impact of transcranial direct current stimulation on fatigue in multiple sclerosis.
Role of Hemichannels in CNS Inflammation and the Inflammasome Pathway.
Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?
Multiple sclerosis-Indian perspective.
Epigenetic in Multiple Sclerosis: Molecular mechanisms and dietary intervention.
Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System.
The relationship between executive functioning, processing speed, and white matter integrity in multiple sclerosis.
Erratum: the neuroradiology journal 26: 3-7, 2013. Diffusion tensor magnetic resonance imaging in patients with multiple sclerosis and its relationship with disability.
An initial top-down proteomic analysis of the standard cuprizone mouse model of multiple sclerosis.
Retinal Layer Segmentation in Patients with Multiple Sclerosis Using Spectral Domain Optical Coherence Tomography.
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis.
Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.
Pseudobulbar affect: prevalence and management.
Demyelinating disease: CSF analysis could aid prediction of conversion from optic neuritis to multiple sclerosis in children.
[Assessment of the high cost drug program on an example of the interferon treatment of multiple sclerosis.]
Isolated dysphagia due to aquaporin-4 autoimmunity.
Pages
« first
‹ previous
…
553
554
555
556
557
558
559
560
561
…
next ›
last »